Compounds > bepafant
Page last updated: 2024-08-24

bepafant and Reperfusion Injury

bepafant has been researched along with Reperfusion Injury in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (66.67)18.2507
2000's2 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bertani, A; Bertani, C; Campodonico, A; Carboni, A; Marchesini, A; Mazzanti, L; Pangrazi, PP; Riccio, M; Scalise, A; Talevi, D1
Bremer, C; Lang, H; Oldhafer, KJ; Pichlmayr, R; Schüttler, W; Spiegel, HU1
Calne, R; Chávez-Cartaya, RE; Jamieson, NV; Metcalfe, S; Ramirez-Romero, P1
Knight, KR; Lepore, DA; Morrison, WA; Riccio, M; Stewart, AG1
Andrade, SP; Cara, DC; Cassali, GD; Coutinho, SF; Poole, SP; Silveira, MR; Souza, DG; Teixeira, MM1
Levine, BA; McCollum, MO; Olson, MS; Zhou, W1

Other Studies

6 other study(ies) available for bepafant and Reperfusion Injury

ArticleYear
Combined use of WEB2170 and HBO therapy can reduce ischemia and reperfusion injury to the skeletal muscle in a rabbit model.
    Microsurgery, 2007, Volume: 27, Issue:1

    Topics: Animals; Azepines; Combined Modality Therapy; Disease Models, Animal; Hyperbaric Oxygenation; Muscle, Skeletal; Peroxidase; Platelet Aggregation Inhibitors; Rabbits; Reperfusion Injury; Triazoles

2007
Beneficial effect of the platelet-activating factor antagonist WEB 2170 on reperfusion injury after orthotopic liver transplantation.
    Transplantation proceedings, 1995, Volume: 27, Issue:5

    Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Azepines; Bilirubin; Body Weight; Graft Survival; Liver; Liver Function Tests; Liver Transplantation; Platelet Activating Factor; Platelet Aggregation Inhibitors; Reperfusion Injury; Swine; Time Factors; Triazoles

1995
Rat liver blood flow after ischemia and reperfusion. The effects of the platelet-activating factor antagonist WEB-2170 and of removing circulating leukocytes.
    Transplantation, 1994, May-27, Volume: 57, Issue:10

    Topics: Animals; Azepines; Liver; Liver Circulation; Male; Neutrophils; Oxyhemoglobins; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Reperfusion Injury; Triazoles; Vinblastine

1994
Platelet-activating factor (PAF) receptor antagonism by WEB 2170 improves the survival of ischaemic skeletal muscle.
    Annals of the Academy of Medicine, Singapore, 1995, Volume: 24, Issue:4 Suppl

    Topics: Animals; Azepines; Creatine Kinase; Ischemia; Lipid Peroxidation; Muscle, Skeletal; Neutrophils; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Rabbits; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Reperfusion Injury; Replantation; Tissue Preservation; Tissue Survival; Triazoles

1995
Effects of the PAF receptor antagonist UK74505 on local and remote reperfusion injuries following ischaemia of the superior mesenteric artery in the rat.
    British journal of pharmacology, 2000, Volume: 131, Issue:8

    Topics: Animals; Azepines; Capillary Permeability; Dihydropyridines; Disease Models, Animal; Dose-Response Relationship, Drug; Imidazoles; Intestine, Small; Male; Mesenteric Artery, Superior; Neutrophils; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Polysaccharides; Rats; Rats, Wistar; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Reperfusion Injury; Triazoles; Tumor Necrosis Factor-alpha

2000
Inflammation and platelet-activating factor production during hepatic ischemia/reperfusion.
    Hepatology (Baltimore, Md.), 1992, Volume: 16, Issue:5

    Topics: Alanine Transaminase; Allopurinol; Animals; Azepines; Gadolinium; Hepatitis; Ischemia; Leukocytes; Liver; Male; Necrosis; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Triazoles

1992